Evidence map›Paper›PMID 41965725›Full record

Trial reportBMC health services research2026

Hearing screening beyond the clinic: Childhood cancer survivors' perspectives on a novel hearing screening program.

Philippa Jörger, Carina Nigg, Leonie Schreck, Christina Schindera, Katharina Fessler, Nicolas Waespe, Zuzana Tomášiková, Marc Ansari, Annika Frahsa, Claudia E Kuehni

Registry-linked trialAbstract readClinical Trial
In one paragraph

Trial report in BMC health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06036407 (Improving Access to Screening for Hearing Loss After Childhood Cancer - a Novel Community-based Approach), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06036407 nacompletednot on this map

Improving Access to Screening for Hearing Loss After Childhood Cancer - a Novel Community-based Approach

TypeinterventionalSponsorUniversity of BernRan2022 to 2024Enrolled476ConditionsChildhood Cancer, Hearing LossArmsHearing test
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Philippa JörgerInstitute of Social and Preventive Medicine, University of Bern, Mittelstrasse 43, Bern, 3012, Switzerland.
Carina NiggInstitute of Social and Preventive Medicine, University of Bern, Mittelstrasse 43, Bern, 3012, Switzerland.
Leonie SchreckInstitute of Social and Preventive Medicine, University of Bern, Mittelstrasse 43, Bern, 3012, Switzerland.
Christina SchinderaInstitute of Social and Preventive Medicine, University of Bern, Mittelstrasse 43, Bern, 3012, Switzerland.
Katharina FesslerInstitute of Social and Preventive Medicine, University of Bern, Mittelstrasse 43, Bern, 3012, Switzerland.
Nicolas WaespeInstitute of Social and Preventive Medicine, University of Bern, Mittelstrasse 43, Bern, 3012, Switzerland.
Zuzana TomášikováChildhood Cancer Switzerland, Basel, Switzerland.
Marc AnsariCANSEARCH Research Platform in Pediatric Oncology and Hematology, Department of Pediatrics, Gynecology and Obstetrics, University of Geneva, Geneva, Switzerland.
Annika Frahsa *Institute of Social and Preventive Medicine, University of Bern, Mittelstrasse 43, Bern, 3012, Switzerland.
Claudia E Kuehni *Institute of Social and Preventive Medicine, University of Bern, Mittelstrasse 43, Bern, 3012, Switzerland. claudia.kuehni@unibe.ch.

Funding

Krebsliga Schweiz KLS/KFS-5711-01-2022Swiss Cancer Research Foundation HSR-4951-11-2019
6 · The paper itself

Abstract

purposeChildhood cancer survivors (CCS) are at risk for late effects including hearing loss due to ototoxic treatments. It is crucial to detect late effects like hearing loss early, but many adult CCS do not attend recommended follow-up care due to barriers such as accessibility and emotional concerns associated with revisiting medical facilities. To address those barriers, the HEAR-study piloted a new hearing screening program leveraging the extensive network of hearing aid shops across Switzerland. This study explored perspectives of CCS on this novel screening program.

methodsWe conducted semistructured interviews with 29 participants who completed pure-tone audiometric screening at a hearing aid shop as part of the HEAR-study. We used thematic analysis of interview transcripts, supported by MAXQDA for data analysis.

resultsThematic analysis revealed two key themes: First, participants appreciated the program's practicality, highlighting its efficiency and ease of integration into daily life. However, some noted concerns about the hearing test being an additional appointment. Some preferred centrally organized follow-up care, where different examinations are done at the same location within the same day. Second, participants valued the personal and approachable environment in hearing aid shops as a relaxed alternative to medical facilities, but some participants preferred hearing tests as part of an appointment with physicians, valuing immediate advice and contextual knowledge, especially in case hearing loss was found.

conclusionsFrom the perspectives of CCS, this screening program shows promise as a practicable, accessible way to evaluate hearing after childhood cancer. Further evaluation from the perspectives of health care providers is needed to comprehensibly assess its feasibility.

trial registrationClinicalTrials.gov "NCT06036407", Registration date: 28.8.2023.

Indexed as

Cancer SurvivorsHearing LossHearing TestsMass ScreeningAdolescentAdultChildFemaleHumansInterviews as TopicMaleMiddle AgedNeoplasmsQualitative ResearchSwitzerlandYoung AdultChildhood cancerHearing problemsHearing screeningLong-term follow-upOtotoxicity

Identifiers

PMID41965725
PMCPMC13196202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.